UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 12b-25
                                                                 SEC FILE NUMBER
                                                                    CUSIP NUMBER
                           NOTIFICATION OF LATE FILING

(Check One): [ ]  Form 10K     [ ]  Form 20-F       [ ]  Form 11-K
             [X]  Form 10-Q    [ ]  Form N-SAR

For Period Ended   March 31, 2001
                   ---------------

[  ]  Transition Report on Form 10-K
[  ]  Transition Report on Form 20-K
[  ]  Transition Report on Form 11-K
[  ]  Transition Report on Form 10-Q
[  ]  Transition Report on Form N-SAR
For the Transition Period Ended:
                                 -----------------------------------------------

- --------------------------------------------------------------------------------
Read Instruction ( on back page) Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the commission has
verified any information contained herein
- --------------------------------------------------------------------------------

If the information relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:
- --------------------------------------------------------------------------------

PART 1: REGISTRANT INFORMATION

Genesis Health Ventures, Inc.
- --------------------------------------------------------------------------------
Full Name of Registrant

Not Applicable
- --------------------------------------------------------------------------------
Former Name If Applicable

101 East State Street
- --------------------------------------------------------------------------------
Address of  Principal Executive Office    ( Street and Number)

Kennett Square, Pennsylvania 19348-3021
- --------------------------------------------------------------------------------
City,  State, and  Zip Code

PART II- Rules 12b- 25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)

[x] (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense:

[x] (b) The subject annual report, semi annual report, transition report Form
10-K , Form 20-F, 11-K or Form N-SAR, or portion thereof, will be filed on or
before the fifteenth calendar day following the prescribed due date; or the
subject quarterly report of transition report on Form 10-Q or portion thereof
will be filed on or before the fifth calendar day following the prescribed due
date ; and

[ ] (c ) the accountant's statement or other exhibit required by rule 12b-25(c)
has been attached if applicable.

Part III - Narrative

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q,
N-SAR or the transition report or portion thereof , could not be filed within
the prescribed time period.

THE FORM 10-Q FOR THE QUARTER ENDED MARCH 31, 2001 COULD NOT BE FILED WITHIN THE
PRESCRIBED PERIOD BECAUSE THE COMPANY WAS UNABLE TO COMPLETE CERTAIN INFORMATION
KEY TO FILING A TIMELY AND ACCURATE REPORT ON THE FINANCIAL CONDITION OF THE
COMPANY. SUCH INABILITY COULD NOT HAVE BEEN ELIMINATED BY THE COMPANY WITHOUT
UNREASONABLE EFFORT OR EXPENSE.




Part IV-Other Information

(1)  Name and Telephone number of person to contact in regard to this
     notification

GEORGE V. HAGER JR.                 (610)                 444-6350
- --------------------------------------------------------------------------------
(Name )                          (Area Code)          (Telephone Number)

(2)  Have all other periodic reports required under section 13 or 15 (d) of the
     Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
     of 1940 during the preceding 12 months for such period that the registrant
     was required to file such report(s) been filed? I answer is no identify
     report (s)

     [ x ]  Yes           [   ]    No

(3)  Is it anticipated that any significant change in the results of operations
     from the corresponding period for the last fiscal year will be reflected by
     the earnings statements to be included in the subject report or portion
     thereof?

     [ x ]  Yes           [   ]    No

     If so attach an explanation of the anticipated change, both narratively and
     quantitatively, and , if appropriate, state the reasons why a reasonable
     estimate of the results cannot be made.

     The Company's filings under Chapter 11 of the United States Bankruptcy Code
     have resulted in approximately $16 million of additional debt restructuring
     and reorganization costs in the six months ended March 31, 2001 as compared
     to the same period in the prior year. In addition, the Company has reduced
     interest expense approximately $44 million, principally due to the fact
     that certain unsecured and under secured loans are not accruing interest as
     a result of the Company's Chapter 11 filings. This reduction is offset by
     growth in interest expense of approximately $7 million due to additional
     borrowings and higher rates of interest on certain loans for which the
     Company is accruing interest.
- --------------------------------------------------------------------------------
                          Genesis Health Ventures, Inc.
- --------------------------------------------------------------------------------
                  Name of (Registrant as Specified in Charter)

     has caused this notification to be signed on its behalf by the undersigned
     hereunto duly authorized

     Date  MAY 16, 2001              By   /S/ GEORGE V. HAGER, JR.
           --------------------           -------------------------------------
                                          Executive Vice President and
                                          Chief Financial Officer

     INSTRUCTION : The form may be signed by an executive officer of the
     registrant or by any other dully authorized representative. The name and
     title of the person signing the form shall be typed or printed beneath the
     signature. If the statement is signed on behalf of the registrant by an
     authorized representative ( other than the executive officer), evidence of
     the representative's authority to sign on behalf of the registrant shall be
     filed with the form.

                                            ATTENTION
- --------------------------------------------         ---------------------------
- --------------------------------------------------------------------------------
           Intentional misstatements or omissions of fact constitute
               Federal Criminal Violations (See 18 U.S.C. _1001)
- --------------------------------------------------------------------------------